Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral midazolam, oral esketamine, and intranasal dexmedetomidine for preoperative anxiety in children
ChiCTR2200063989Phase 4Not yet recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam, esketamine and dexmedetomidine in preoperative anxiety and separation anxiety disorder (SAD) (3 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoints: Separation Anxiety Score from Parents (PSAS), Mask Induction Acceptance Score and 1 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
midazolamesketaminedexmedetomidine
03
Conditions
preoperative anxietyseparation anxiety disorder (SAD)
Beyond the preview
Go deeper on ChiCTR2200063989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063989.